Sign in
4

Changes in Ownership

Taysha Gene Therapies, Inc. Filed Acc 0001209191-20-052460

Director acquired 19,226 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Nagendran Sukumar Director 2020-09-28 Conversion +19,226 19,226 D
Derivatives
Nagendran Sukumar Director 2020-09-28 Conversion · Series B Preferred Stock −17,647 0 D
Loading xslF345X03/doc4.xml…